• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO2; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2104
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Seroma (2069); Swelling/ Edema (4577)
Event Date 06/05/2023
Event Type  Injury  
Event Description
A barostim system was implanted on (b)(4) 2023.On (b)(4) 2023, the patient experienced swelling and fluid build-up at the ipg pocket location.A replacement procedure occurred on (b)(4) 2023 where the ipg was explanted, and a new ipg placed.In the opinion of the physician, a possible seroma contributed to the pocket complication.Samples were sent to pathology for further analysis, and the patient was placed on antibiotics.
 
Manufacturer Narrative
The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Cvrx id# (b)(6).
 
Event Description
A barostim system was implanted on (b)(6) 2023.On (b)(6) 2023, the patient experienced swelling and fluid build-up at the ipg pocket location.The patient was admitted to the hospital on (b)(6) 2023, and iv antibiotics were administered.A replacement procedure occurred on (b)(6) 2023 where the ipg was explanted, and a new ipg placed.In the opinion of the physician, a seroma occurred that had been caused by the initial implant procedure.Samples were sent to pathology for further analysis, and all cultures were negative.The patient was discharged home on (b)(6) 2023.The patient recovered with no complications, and their wound was healing.
 
Manufacturer Narrative
Cvrx id#: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO2
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer Contact
sarah hicks
9201 west broadway avenue
suite 650
minneapolis, MN 55445
MDR Report Key17248513
MDR Text Key318302711
Report Number3007972010-2023-00028
Device Sequence Number1
Product Code DSR
UDI-Device Identifier00859144004623
UDI-Public(01)00859144004623(17)240920
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number2104
Device Catalogue Number100065-202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
Patient RaceWhite
-
-